Navigating the impact of COVID-19 on palliative care for head and neck cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32338809.
- Also identified by DOI 10.1002/hed.26211 and PMC identifier 7267519.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Health care services are being confronted by a daily dilemma of who can receive critical care and who cannot. In a palliative care clinic, this apprehension gets exemplified, as these patients have limited life expectancy. The head and neck region further makes things critical, as it comprises of all the sites through which the SARS-CoV-2 can be transmitted. This document strives to define the ways in which the head and neck cancer services can contribute to better patient care in a triage context. Practical steps suggested are protective equipment use, ensuring access to critical drugs (such as opioids), greater use of telemedicine consultations, discussing advance care plans, and embracing the role of a wider community support.
Medical subject headings
- Communicable Disease Control
- Coronavirus Infections
- Delivery of Health Care
- Head and Neck Neoplasms
- Palliative Care
- Pandemics
- Pneumonia, Viral